Cyprus vs South Korea: Share of E. coli infections resistant to cephalosporins
Cyprus
40.5%
in 2022
South Korea
38.8%
in 2022
Cyprus rank
20th
South Korea rank
21st
Share of E. coli infections resistant to cephalosporins over time
- Cyprus
- South Korea
How they compare
Cyprus currently reports 40.5% against 38.8% in South Korea, a difference of 1.7%.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was South Korea ahead.
Cyprus ranks 20th and South Korea ranks 21st of 46 countries.
Across the 2 decades both report, Cyprus averaged higher in 1 and South Korea in 1.
Head to head by decade
| Decade | Cyprus | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.2% | 36.0% | 6.9% | South Korea |
| 2020s | 44.4% | 37.7% | 6.7% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Cyprus or South Korea?
- Cyprus, at 40.5% against 38.8% in South Korea as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Cyprus and South Korea?
- 1.7%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and South Korea?
- 6 years are reported by both, from 2017 to 2022.
- How do Cyprus and South Korea rank globally for share of e. coli infections resistant to cephalosporins?
- Cyprus ranks 20th and South Korea ranks 21st of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).